<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0019">
 <element-citation publication-type="journal" id="sbref0019">
  <person-group person-group-type="author">
   <name>
    <surname>Polman</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>O'Connor</surname>
    <given-names>P.W.</given-names>
   </name>
   <name>
    <surname>Havrdova</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hutchinson</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kappos</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Theodore Phillips</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lublin</surname>
    <given-names>F.D.</given-names>
   </name>
   <name>
    <surname>Giovannoni</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wajgt</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Toal</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lynn</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Panzara</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Sandrock</surname>
    <given-names>A.W.</given-names>
   </name>
  </person-group>
  <article-title>A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2006</year>
  <pub-id pub-id-type="doi">10.1056/nejmoa044397</pub-id>
  <comment>https://doi.org/</comment>
 </element-citation>
</ref>
